ris Mendeley, Papers, Flaxseeds for preventing cancer. Further, the sites of glucose disposal in glucagon deficient Deficienccy treated mice given an oral glucose tolerance test should be identified, and the flux rates and signaling pathways involved in glucose disposal should be determined. Burgess et al.

Glucagon deficiency -

November 21, Piero P. Foà, MD, PhD ; Joseph C. Dunbar Jr, PhD ; Sander P. Klein, MD ; et al Stanley H. Levy, MD ; Magsood A. Malik, MD ; Barbara B. Campbell, MS ; Naomi L. Foà, MS. Author Affiliations From the Department of Research, Sinai Hospital of Detroit Drs Foà, Dunbar, Klein, Levy, and Malik, Ms Campbell, and Ms Foà , and the Department of Physiology, Wayne State University School of Medicine, Detroit Drs Foà and Dunbar.

visual abstract icon Visual Abstract. Access through your institution. Add or change institution. Download PDF Full Text Cite This Citation Foà PP , Dunbar JC , Klein SP, et al. Select Your Interests Customize your JAMA Network experience by selecting one or more topics from the list below.

Save Preferences. Privacy Policy Terms of Use. Access your subscriptions. Free access to newly published articles. Purchase access.

Endocrine deficiency states are of interest mainly for two reasons: 1 they can serve as experiments of nature, helping us to understand the physiologic roles of deficient hormones; and 2 they may be important disease entities. Chronic, severe glucagon deficiency has recently been shown to exist in human subjects after total duodenopancreatectomy and hemigastrectomy.

Furthermore, pharmacologic approaches to suppress glucagon release have been employed successfully to create acute and transient states of glucagon deficiency. Data obtained with these techniques have greatly expanded our knowledge of the physiologic role of glucagon.

In this chapter, we will review the literature on surgically and pharmacologically induced as well as on naturally occurring states of glucagon deficiency and on the effects of glucagon deficiency on protein and carbohydrate metabolism. Because of the lack of published work on the effects of selective glucagon deficiency on ketogenesis, lipolysis, and lipoprotein metabolism, these aspects of glucagon activity are not discussed.

Glucagon refers to the 3, dal- tons moiety IRG whereas IRG refers to total immunoreactive glucagon which includes various bioactive and bioinactive glucagon species. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, log in via an institution. Unable to display preview. Download preview PDF. Alford FP, Bloom SR, Nabarro JDN, Hall R, Besser GM, Coy DH, Kastin AJ, Schally AV Glucagon control of fasting glucose in man.

Lancet 2: — Article PubMed CAS Google Scholar. Ardaillou R, Paillard F Metabolism of polypeptide hormones by the kidney. Adv Nephrol 9: — CAS Google Scholar.

Bhathena SJ, Voyles NR, Smith S, Recant L Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia.

J Clin Invest — Bilbrey GL, Faloona GR, White MG, Knöchel JP Hyperglucagonemia of renal failure. Bilbrey GL, Faloona GR, White MG, Atkins C, Hull AR, Knöchel JP Hyperglucagonemia in uremia: reversal by renal transplantation.

Ann Intern Med — PubMed CAS Google Scholar. Block MD, Rubenstein AH Spontaneous hypoglycemia in diabetes with renal insufficiency. JAMA — Article Google Scholar.

Cerietty JM, Engbring NH Azotemia and glucose intolerance. Google Scholar. Cohen BD Abnormal carbohydrate metabolism in renal disease. Blood glucose unresponsiveness to hypoglycemia, epinephrine, and glucagon. DeFronzo RA Pathogenesis of glucose intolerance in uremia. Metabolism — DeFronzo RA, Andres AR, Edgar P, Walker WG Carbohydrate metabolism in uremia: a review.

Medicine Baltimore — Article CAS Google Scholar. Emmanouel DS, Jaspan JB, Kuku SF, Rubenstein AH, Katz AI Pathogenesis and characterization of hyperglucagonemia in the uremic rat.

Emmanouel DS, Jaspan JB, Rubenstein AH, Huen A, Fink E, Katz AI Glucagon metabolism in the rat: contribution of the kidney to the metabolic clearance rate of the hormone. J Clin Invest 6— Emmanouel DS, Lindheimer MD, Katz AI Pathogenesis of endocrine abnormalities in uremia.

Endocr Rev 1: 28— Feldman HA, Singer I Endocrinology and metabolism in uremia and dialysis: a clinical review. Flanagan RW, Murphy RF, Buchanan KD Circulating forms of glucagon and related peptides in normal subjects and uremic patients. Biochem Soc Trans 8: — JASPAN etal.

Frizzell M, Larsen PR, Field JB Spontaneous hypoglycemia associated with chronic renal failure. Diabetes — Fröhlich J, Schölmerich J, Hoppe—Seyler G, Maier KP, Talke H, Schollmeyer P, Gerok W The effect of acute uraemia on gluconeogenesis in isolated perfused rat livers.

Eur J Clin Invest 4: — PubMed Google Scholar. Garber A J, Bier DM, Cryer PE, Pagliara AS Hypoglycemia in compensated chronicrenal insufficiency. Substrate limitation of gluconeogenesis. Gavin JR, Roth J, Neville DM Jr, DeMeyts P, Buell DN Insulin—dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

Proc Natl Acad Sci USA 84— Greenblatt DJ Fatal hypoglycemia occurring after peritoneal dialysis. Br Med J 1: — Hampers CL Effect of chronic renal failure and hemodialysis on carbohydrate metabolism.

Hellerström C, Howell SL, Edwards JC, Anderson A, Östenson Biosynthesis of glucagon in isolated pancreatic islets of guinea pigs. Biochem J 13— Horton ES, Johson C, Lebovitz HE Carbohydrate metabolism in uremia.

Ann Intern Med 63— Hutchings RH, Hegstrom RM, Scribner BH Glucose intolerance in patients on longterm intermittent dialysis. Jaspan JB, Rubenstein AH Circulating glucagon: plasma profiles and metabolism in health and disease.

Jaspan JB, Kuku S, Locker J, Huen A, Emmanouel DS, Katz AI, Rubenstein AH Heterogeneity of plasma glucagon in man. Metabolism 25 [Suppl 1]: — Jaspan JB, Huen A, Gonen B, Rubenstein AH Circulating glucagon components: significance in health and disease.

In: Foä PP, Bajaj JS, Foä NL eds Glucagon: its role in physiology and clinical medicine. Springer, Berlin Heidelberg New York, pp 93— Jaspan JB, Polonsky KS, Lewis M, Pensler J, Pugh W, Moossa AR, Rubenstein AH a Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon.

Am J Physiol E— Jaspan JB, Polonsky KS, Rubenstein AH b The heterogeneity of immunoreactive glucagon in plasma: clinical implications. In: Current endocrinology.

Katsilambros N, Heding LG Plasma glucagon levels in acute experimental uremia resulting from bilateral nephrectomy and bilateral ureter ligation in the rat. Int Res Commun Syst Med Sci 3: Katz AI, Emmanouel DS Metabolism of polypeptide hormones by the normal kidney and in uremia. Nephron 69— Kuku SF, Zeidler A, Emmanouel DS, Katz AI, Rubenstein AH, Levin NW, Tello A a Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.

J Clin Endocrinol Metab — Kuku SF, Jaspan JB, Emmanouel DS, Zeidler A, Katz AI, Rubenstein AH b Heterogeneity of plasma glucagon: circulating components in normal subjects and patients with chronic renal failure. Lefebvre PJ, Luyckx AS Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog.

Metab Clin Exp — Lefebvre PJ, Luyckx AS, Nizet AH Renal handling of endogenous glucagon in the dog: comparison with insulin. Metabolism — Lowrie EG, Soeldner JS, Hampers CL, Merrill JB Glucose metabolism and insulin secretion in uremic, prediabetic, and normal subjects.

J Lab Clin Med — Marumo F, Sakai T, Sato S Response of insulin, glucagon and growth hormone to arginine infusion in patients with chronic renal failure. Nephron 81— Mashiter K, Harding PE, Chou M, Mashiter GD, Stout J, Diamond D, Field JB Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.

Endocrinology — Mataverde A, El—Ravi R, Cohen M Spontaneous hypoglycemia in chronic renal failure Abstr. Clin Res A. Noe BD, Bauer GE Evidence for glucagon biosynthesis involving a protein intermediate in islets of the angler fish Lophius americanus.

Noe BD, Bauer GE Evidence for sequential metabolic cleavage of proglucagon to glucagon in glucagon biosynthesis. Noe BD, Bauer GE, Steffes MW, Sutherland DER, Najarian JS Glucagon biosynthesis in human pancreatic islets: preliminary evidence for a biosynthetic intermediate.

Horm Metab Res 7: — Metabolism 76— Article PubMed Google Scholar. Posner BI, Kelly PA, Friesen HG Prolactin receptors in rat liver: possible induction by prolactin.

Science 57— Rabau M, Dor J, Adar R, Walden R, Mozes M Spontaneous hypoglycemia in a diabetic patient with renal failure.

Isr J Med Sci 9: — Sherwin RS, Bastl C, Finkelstein FO, Fisher M, Black H, Hendler R, Felig P a Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon. Sherwin RS, Fisher M, Hendler R, Felig P b Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.

N Engl J Med — Soman V, Felig P Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model. Soman V, Felig P Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulintreated diabetic rats.

J clin Invest — Spitz IM, Rubenstein AH, Bersohn C, Abrahams C, Lowy C Carbohydrate metabolism in renal disease. Q J Med — Swenson RS, Peterson DT, Eshleman M, Reaven GM Effect of acute uremia on various aspects of carbohydrate metabolism in dogs.

Kidney Int 4: — Tager HS, Steiner DF Isolation of a glucagon—containing peptide. Primary structure of a possible fragment of proglucagon. Proc Natl Acad Sci USA —

The deficiehcy of ddeficiency female patient with fasting Homeopathic remedies for migraines before the development of Type 1 insulin-dependent diabetes defiviency is reported. She Glucgaon with primary hypothyroidism, partial hypopituitarism, adrenal insufficiency Endurance running techniques glucagon deficiency. Thyroid microsomal and Glucagon deficiency parietal cell antibodies Flaxseeds for preventing cancer defixiency as well as Energy boosters for immune system support, whereas islet cell antibodies were not demonstrable, even 2 years after the onset of diabetes. After an overnight fast, moderate hyperaminoacidaemia was found with elevations of alanine, glycine, serine, arginine and ornithine as seen in pancreatectomized patients. It is suggested that the deficient glucagon secretion in this patient might, at least in part, have been the cause of fasting hypoglycaemia and the failure of glucose recovery following insulin-induced hypoglycaemia. Possibly, the A cell deficiency was part of the polyglandular failure syndrome in this patient. Download to read the full article text.